Abstract
Citing growing demand for small-molecule drug development and production, Cambrex says it will spend $50 million to expand its capacity to make active pharmaceutical ingredients in Charles City, Io...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
